Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2021
Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE)Simon J Crabb, Sarah Danson, James W F Catto, et al.
British Journal of Cancer|May 27, 2026
Depth of response to primary POMB/ACE chemotherapy predicts survival in poor prognosis germ-cell tumoursEmily Hobbs, Lara Ulrich, Anand Sharma, et al.
JAMA Oncology|September 13, 2019
Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With CancerDavid J Pinato, Sarah Howlett, Diego Ottaviani, et al.
BMJ Medicine|May 1, 2025
Monitoring complete hydatidiform molar pregnancies after normalisation of human chorionic gonadotrophin: national retrospective population studyBrenna E Swift, Leonoor Coopmans, Kam Singh, et al.
The Lancet. Oncology|June 28, 2021
Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort studyAntonio Braga, Gabriela Paiva, Ehsan Ghorani, et al.
JAMA Oncology|June 3, 2016
Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal CancerThomas Powles, Naveed Sarwar, Andrew Stockdale, et al.
BMJ Open|November 19, 2021
Metastatic prostate cancer men's attitudes towards treatment of the local tumour and metastasis evaluative research (IP5-MATTER): protocol for a prospective, multicentre discrete choice experiment studyMartin John Connor, Mesfin G Genie, Michael Gonzalez, et al.
The Oncologist|August 17, 2023
Patient-Reported Outcomes in KEYNOTE-564: Adjuvant Pembrolizumab Versus Placebo for Renal Cell CarcinomaToni K Choueiri, Piotr Tomczak, Se Hoon Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2026
Malignant Adult Ovarian Germ Cell Tumors: An International Multicenter Study to Identify Relevant Prognostic Risk Factors for Stage IC and BeyondAlice Bergamini, Suyanto Suyanto, Constantinos Savva, et al.
The Lancet. Oncology|September 2, 2022
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialThomas Powles, Piotr Tomczak, Se Hoon Park, et al.
Pageof 5